NYSE$FIGS

FIGS Inc. · Q4 2021 earnings

Q4 2021 earnings · · Investor relations

Briefing

FIGS experienced revenue growth and maintained strong gross margins in Q4 2021.

FIGS reported a 42.7% increase in net revenues to $128.7 million and a gross margin of 69.9% for the fourth quarter of 2021. Net income was $12.6 million, with diluted earnings per share of $0.06. The company's full-year net revenues reached $420 million, a 60% increase year-over-year.

  • Net revenues increased by 42.7% year over year to $128.7 million.
  • Gross margin was 69.9%, a decrease of 110 basis points year over year.
  • Net income was $12.6 million and diluted earnings per share was $0.06.
  • Adjusted EBITDA was $31.9 million, an increase of $10.5 million year over year.

Headline financials

Total Revenue

$129M

Previous: $90.2M+42.7%
EPS (adj)

$0.09

Previous: -$0.21+142.0%
Active Customers

1.9M

No prior period
Net Revenues per Active Customer

$224.00

No prior period
Average Order Value

$113.00

No prior period
Capital Expenditures

$704K

Previous: $2.26M-68.9%
Free Cash Flow

$13.2M

Previous: -$3.5M+477.5%
Net Income

$12.6M

Previous: $12.1M+3.9%
Operating Income

$16.4M

Previous: $12.8M+28.7%
Gross Profit

$90.1M

Previous: $64.1M+40.6%
Cash & Equivalents

$195M

Previous: $58.1M+236.1%
Total Assets

$312M

Previous: $134M+132.9%
Stock-Based Comp

$12.9M

Previous: $7.73M+66.3%

Revenue & EPS history

FIGS · Revenue · Quarterly

$129M

Q4 2021+42.7%vs Q4 2020
Beat estimate in 8 of 11 quarters(73%)
ActualEstimate

Forward guidance

FIGS expects net revenues between $550 million and $560 million, a gross margin of 70%+, and an adjusted EBITDA margin of 20%+ for the full year 2022.

Tailwinds

  • Net Revenues $550 Million - $560 Million
  • Gross Margin 70%+
  • Adjusted EBITDA Margin 20%+
  • Company expects continued growth
  • Company expects to maintain strong gross margins

Headwinds

  • Impact of COVID-19 on the Company’s operations
  • Company’s ability to maintain its recent rapid growth
  • Company’s ability to maintain profitability
  • Company’s ability to maintain the value and reputation of its brand
  • The competitiveness of the market for healthcare apparel

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2021

Historical avgQ4 2021

+0.0%

Avg return

Earnings day

-0.5%

Avg return

5 days after

+0.7%

Avg return

30 days after

61%

14 / 23 earnings

Positive

+28.7%

Q3 2023

Best reaction

-25.4%

Q3 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+6.0%-20.7%-18.1%
Q4 2025+23.5%+36.1%+17.9%
Q3 2025+14.1%+33.2%+52.0%
Q1 2025-1.7%-13.5%-12.2%
Q4 2024-18.1%-13.3%-15.8%
Q3 2024-25.4%-26.5%-20.6%
Q2 2024-11.0%-12.1%+4.3%
Q1 2024+4.7%+16.5%+6.2%
Q4 2023-12.2%-7.2%-16.4%
Q3 2023+28.7%+21.4%+41.8%
Q2 2023+1.3%-2.9%-11.0%
Q1 2023+7.2%+10.2%+18.1%
Q4 2022-25.1%-25.7%-32.8%
Q3 2022+15.6%+10.7%+23.7%
Q2 2022+3.4%+3.3%+0.6%
Q1 2022-21.8%-17.4%-37.1%
Q4 2021+27.5%+22.0%+64.5%
Q3 2020-15.1%-16.1%-38.7%
Q3 2021-15.1%-16.1%-38.7%
Q2 2020+3.6%+1.5%+6.8%
Q1 2021+3.6%+1.5%+6.8%
Q2 2021+3.6%+1.5%+6.8%
Q4 2020+3.6%+1.5%+6.8%
Q1 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro